aluates Reports

$ 0.0

Automative

Hospital-Acquired Infection (HAI) Diagnostic - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-13H8430

Global and Japan Hospital Acquired Infection HAI Diagnostic Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Hospital-Acquired Infection (HAI) Diagnostic - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-13H8430

Report

October 2024

Pages:106

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

bioMérieux

Abbott Laboratories

Alere Inc

Roche

Siemens Healthcare

Becton Dickenson

Cepheid Inc

Thermo Fisher Scientific

Seegene

Qiagen NV

Hospital-Acquired Infection (HAI) Diagnostic - Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Hospital-Acquired Infection (HAI) Diagnostic - Market

A hospital-acquired infection (HAI) is an infection whose development is favoured by a hospital environment, such as one acquired by a patient during a hospital visit. The most common types are bloodstream infection (BSI), pneumonia (eg, ventilator-associated pneumonia [VAP]), urinary tract infection (UTI), and surgical site infection (SSI).

The global market for Hospital-Acquired Infection (HAI) Diagnostic was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hospital-Acquired Infection (HAI) Diagnostic, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Hospital-Acquired Infection (HAI) Diagnostic by region & country, by Type, and by Application.

The Hospital-Acquired Infection (HAI) Diagnostic market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital-Acquired Infection (HAI) Diagnostic.

Market Segmentation

Scope of Hospital-Acquired Infection (HAI) Diagnostic - Market Report

Report Metric	Details
Report Name	Hospital-Acquired Infection (HAI) Diagnostic - Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type:	Molecular Diagnostics Blood Tests Urinalysis
Segment by Application	Urinary Tract Infections Pneumonia Surgical Site Infections Bloodstream Infections Other Hospital Infections
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	bioMérieux, Abbott Laboratories, Alere, Inc., Roche, Siemens Healthcare, Becton Dickenson, Cepheid Inc., Thermo Fisher Scientific, Seegene, Inc., Qiagen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hospital-Acquired Infection (HAI) Diagnostic manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Hospital-Acquired Infection (HAI) Diagnostic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Hospital-Acquired Infection (HAI) Diagnostic in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Hospital-Acquired Infection (HAI) Diagnostic - Market report?

Ans: The main players in the Hospital-Acquired Infection (HAI) Diagnostic - Market are bioMérieux, Abbott Laboratories, Alere, Inc., Roche, Siemens Healthcare, Becton Dickenson, Cepheid Inc., Thermo Fisher Scientific, Seegene, Inc., Qiagen

What are the Application segmentation covered in the Hospital-Acquired Infection (HAI) Diagnostic - Market report?

Ans: The Applications covered in the Hospital-Acquired Infection (HAI) Diagnostic - Market report are Urinary Tract Infections, Pneumonia, Surgical Site Infections, Bloodstream Infections, Other Hospital Infections

What are the Type segmentation covered in the Hospital-Acquired Infection (HAI) Diagnostic - Market report?

Ans: The Types covered in the Hospital-Acquired Infection (HAI) Diagnostic - Market report are Molecular Diagnostics, Blood Tests, Urinalysis

Recommended Reports

Hospital Infection Diagnostics

Hospital Equipment Systems

Hospital Hygiene Solutions

1 Market Overview

1.1 Hospital-Acquired Infection (HAI) Diagnostic Product Introduction

1.2 Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Forecast

1.3 Hospital-Acquired Infection (HAI) Diagnostic Market Trends & Drivers

1.3.1 Hospital-Acquired Infection (HAI) Diagnostic Industry Trends

1.3.2 Hospital-Acquired Infection (HAI) Diagnostic Market Drivers & Opportunity

1.3.3 Hospital-Acquired Infection (HAI) Diagnostic Market Challenges

1.3.4 Hospital-Acquired Infection (HAI) Diagnostic Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Hospital-Acquired Infection (HAI) Diagnostic Players Revenue Ranking (2023)

2.2 Global Hospital-Acquired Infection (HAI) Diagnostic Revenue by Company (2019-2024)

2.3 Key Companies Hospital-Acquired Infection (HAI) Diagnostic Manufacturing Base Distribution and Headquarters

2.4 Key Companies Hospital-Acquired Infection (HAI) Diagnostic Product Offered

2.5 Key Companies Time to Begin Mass Production of Hospital-Acquired Infection (HAI) Diagnostic

2.6 Hospital-Acquired Infection (HAI) Diagnostic Market Competitive Analysis

2.6.1 Hospital-Acquired Infection (HAI) Diagnostic Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Hospital-Acquired Infection (HAI) Diagnostic Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-Acquired Infection (HAI) Diagnostic as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Molecular Diagnostics

3.1.2 Blood Tests

3.1.3 Urinalysis

3.2 Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Type

3.2.1 Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value, by Type (2019-2030)

3.2.3 Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Urinary Tract Infections

4.1.2 Pneumonia

4.1.3 Surgical Site Infections

4.1.4 Bloodstream Infections

4.1.5 Other Hospital Infections

4.2 Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Application

4.2.1 Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value, by Application (2019-2030)

4.2.3 Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Region

5.1.1 Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Region (2019-2024)

5.1.3 Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Region (2025-2030)

5.1.4 Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Hospital-Acquired Infection (HAI) Diagnostic Sales Value, 2019-2030

5.2.2 North America Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Hospital-Acquired Infection (HAI) Diagnostic Sales Value, 2019-2030

5.3.2 Europe Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Hospital-Acquired Infection (HAI) Diagnostic Sales Value, 2019-2030

5.4.2 Asia Pacific Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Hospital-Acquired Infection (HAI) Diagnostic Sales Value, 2019-2030

5.5.2 South America Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Sales Value, 2019-2030

5.6.2 Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Hospital-Acquired Infection (HAI) Diagnostic Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Hospital-Acquired Infection (HAI) Diagnostic Sales Value

6.3 United States

6.3.1 United States Hospital-Acquired Infection (HAI) Diagnostic Sales Value, 2019-2030

6.3.2 United States Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Hospital-Acquired Infection (HAI) Diagnostic Sales Value, 2019-2030

6.4.2 Europe Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Hospital-Acquired Infection (HAI) Diagnostic Sales Value, 2019-2030

6.5.2 China Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Type (%), 2023 VS 2030

6.5.3 China Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Hospital-Acquired Infection (HAI) Diagnostic Sales Value, 2019-2030

6.6.2 Japan Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Hospital-Acquired Infection (HAI) Diagnostic Sales Value, 2019-2030

6.7.2 South Korea Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Hospital-Acquired Infection (HAI) Diagnostic Sales Value, 2019-2030

6.8.2 Southeast Asia Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Hospital-Acquired Infection (HAI) Diagnostic Sales Value, 2019-2030

6.9.2 India Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Type (%), 2023 VS 2030

6.9.3 India Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 bioMérieux

7.1.1 bioMérieux Profile

7.1.2 bioMérieux Main Business

7.1.3 bioMérieux Hospital-Acquired Infection (HAI) Diagnostic Products, Services and Solutions

7.1.4 bioMérieux Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$ Million) & (2019-2024)

7.1.5 bioMérieux Recent Developments

7.2 Abbott Laboratories

7.2.1 Abbott Laboratories Profile

7.2.2 Abbott Laboratories Main Business

7.2.3 Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Products, Services and Solutions

7.2.4 Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$ Million) & (2019-2024)

7.2.5 Abbott Laboratories Recent Developments

7.3 Alere, Inc.

7.3.1 Alere, Inc. Profile

7.3.2 Alere, Inc. Main Business

7.3.3 Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Products, Services and Solutions

7.3.4 Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$ Million) & (2019-2024)

7.3.5 Roche Recent Developments

7.4 Roche

7.4.1 Roche Profile

7.4.2 Roche Main Business

7.4.3 Roche Hospital-Acquired Infection (HAI) Diagnostic Products, Services and Solutions

7.4.4 Roche Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$ Million) & (2019-2024)

7.4.5 Roche Recent Developments

7.5 Siemens Healthcare

7.5.1 Siemens Healthcare Profile

7.5.2 Siemens Healthcare Main Business

7.5.3 Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Products, Services and Solutions

7.5.4 Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$ Million) & (2019-2024)

7.5.5 Siemens Healthcare Recent Developments

7.6 Becton Dickenson

7.6.1 Becton Dickenson Profile

7.6.2 Becton Dickenson Main Business

7.6.3 Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Products, Services and Solutions

7.6.4 Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$ Million) & (2019-2024)

7.6.5 Becton Dickenson Recent Developments

7.7 Cepheid Inc.

7.7.1 Cepheid Inc. Profile

7.7.2 Cepheid Inc. Main Business

7.7.3 Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Products, Services and Solutions

7.7.4 Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$ Million) & (2019-2024)

7.7.5 Cepheid Inc. Recent Developments

7.8 Thermo Fisher Scientific

7.8.1 Thermo Fisher Scientific Profile

7.8.2 Thermo Fisher Scientific Main Business

7.8.3 Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Products, Services and Solutions

7.8.4 Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$ Million) & (2019-2024)

7.8.5 Thermo Fisher Scientific Recent Developments

7.9 Seegene, Inc.

7.9.1 Seegene, Inc. Profile

7.9.2 Seegene, Inc. Main Business

7.9.3 Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Products, Services and Solutions

7.9.4 Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$ Million) & (2019-2024)

7.9.5 Seegene, Inc. Recent Developments

7.10 Qiagen

7.10.1 Qiagen Profile

7.10.2 Qiagen Main Business

7.10.3 Qiagen Hospital-Acquired Infection (HAI) Diagnostic Products, Services and Solutions

7.10.4 Qiagen Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$ Million) & (2019-2024)

7.10.5 Qiagen Recent Developments

8 Industry Chain Analysis

8.1 Hospital-Acquired Infection (HAI) Diagnostic Industrial Chain

8.2 Hospital-Acquired Infection (HAI) Diagnostic Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Hospital-Acquired Infection (HAI) Diagnostic Sales Model

8.5.2 Sales Channel

8.5.3 Hospital-Acquired Infection (HAI) Diagnostic Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

bioMérieux

Abbott Laboratories

Alere Inc

Roche

Siemens Healthcare

Becton Dickenson

Cepheid Inc

Thermo Fisher Scientific

Seegene

Qiagen NV

List of Tables

Table 1. Hospital-Acquired Infection (HAI) Diagnostic Market Trends

Table 2. Hospital-Acquired Infection (HAI) Diagnostic Market Drivers & Opportunity

Table 3. Hospital-Acquired Infection (HAI) Diagnostic Market Challenges

Table 4. Hospital-Acquired Infection (HAI) Diagnostic Market Restraints

Table 5. Global Hospital-Acquired Infection (HAI) Diagnostic Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Hospital-Acquired Infection (HAI) Diagnostic Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Hospital-Acquired Infection (HAI) Diagnostic Product Type

Table 9. Key Companies Time to Begin Mass Production of Hospital-Acquired Infection (HAI) Diagnostic

Table 10. Global Hospital-Acquired Infection (HAI) Diagnostic Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-Acquired Infection (HAI) Diagnostic as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Hospital-Acquired Infection (HAI) Diagnostic Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Hospital-Acquired Infection (HAI) Diagnostic Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Hospital-Acquired Infection (HAI) Diagnostic Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Hospital-Acquired Infection (HAI) Diagnostic Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Region (2019-2024) & (%)

Table 27. Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Hospital-Acquired Infection (HAI) Diagnostic Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Hospital-Acquired Infection (HAI) Diagnostic Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Hospital-Acquired Infection (HAI) Diagnostic Sales Value, (2025-2030) & (US$ Million)

Table 31. bioMérieux Basic Information List

Table 32. bioMérieux Description and Business Overview

Table 33. bioMérieux Hospital-Acquired Infection (HAI) Diagnostic Products, Services and Solutions

Table 34. Revenue (US$ Million) in Hospital-Acquired Infection (HAI) Diagnostic Business of bioMérieux (2019-2024)

Table 35. bioMérieux Recent Developments

Table 36. Abbott Laboratories Basic Information List

Table 37. Abbott Laboratories Description and Business Overview

Table 38. Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Products, Services and Solutions

Table 39. Revenue (US$ Million) in Hospital-Acquired Infection (HAI) Diagnostic Business of Abbott Laboratories (2019-2024)

Table 40. Abbott Laboratories Recent Developments

Table 41. Alere, Inc. Basic Information List

Table 42. Alere, Inc. Description and Business Overview

Table 43. Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Products, Services and Solutions

Table 44. Revenue (US$ Million) in Hospital-Acquired Infection (HAI) Diagnostic Business of Alere, Inc. (2019-2024)

Table 45. Alere, Inc. Recent Developments

Table 46. Roche Basic Information List

Table 47. Roche Description and Business Overview

Table 48. Roche Hospital-Acquired Infection (HAI) Diagnostic Products, Services and Solutions

Table 49. Revenue (US$ Million) in Hospital-Acquired Infection (HAI) Diagnostic Business of Roche (2019-2024)

Table 50. Roche Recent Developments

Table 51. Siemens Healthcare Basic Information List

Table 52. Siemens Healthcare Description and Business Overview

Table 53. Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Products, Services and Solutions

Table 54. Revenue (US$ Million) in Hospital-Acquired Infection (HAI) Diagnostic Business of Siemens Healthcare (2019-2024)

Table 55. Siemens Healthcare Recent Developments

Table 56. Becton Dickenson Basic Information List

Table 57. Becton Dickenson Description and Business Overview

Table 58. Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Products, Services and Solutions

Table 59. Revenue (US$ Million) in Hospital-Acquired Infection (HAI) Diagnostic Business of Becton Dickenson (2019-2024)

Table 60. Becton Dickenson Recent Developments

Table 61. Cepheid Inc. Basic Information List

Table 62. Cepheid Inc. Description and Business Overview

Table 63. Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Products, Services and Solutions

Table 64. Revenue (US$ Million) in Hospital-Acquired Infection (HAI) Diagnostic Business of Cepheid Inc. (2019-2024)

Table 65. Cepheid Inc. Recent Developments

Table 66. Thermo Fisher Scientific Basic Information List

Table 67. Thermo Fisher Scientific Description and Business Overview

Table 68. Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Products, Services and Solutions

Table 69. Revenue (US$ Million) in Hospital-Acquired Infection (HAI) Diagnostic Business of Thermo Fisher Scientific (2019-2024)

Table 70. Thermo Fisher Scientific Recent Developments

Table 71. Seegene, Inc. Basic Information List

Table 72. Seegene, Inc. Description and Business Overview

Table 73. Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Products, Services and Solutions

Table 74. Revenue (US$ Million) in Hospital-Acquired Infection (HAI) Diagnostic Business of Seegene, Inc. (2019-2024)

Table 75. Seegene, Inc. Recent Developments

Table 76. Qiagen Basic Information List

Table 77. Qiagen Description and Business Overview

Table 78. Qiagen Hospital-Acquired Infection (HAI) Diagnostic Products, Services and Solutions

Table 79. Revenue (US$ Million) in Hospital-Acquired Infection (HAI) Diagnostic Business of Qiagen (2019-2024)

Table 80. Qiagen Recent Developments

Table 81. Key Raw Materials Lists

Table 82. Raw Materials Key Suppliers Lists

Table 83. Hospital-Acquired Infection (HAI) Diagnostic Downstream Customers

Table 84. Hospital-Acquired Infection (HAI) Diagnostic Distributors List

Table 85. Research Programs/Design for This Report

Table 86. Key Data Information from Secondary Sources

Table 87. Key Data Information from Primary Sources

Table 88. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Hospital-Acquired Infection (HAI) Diagnostic Product Picture

Figure 2. Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value (2019-2030) & (US$ Million)

Figure 4. Hospital-Acquired Infection (HAI) Diagnostic Report Years Considered

Figure 5. Global Hospital-Acquired Infection (HAI) Diagnostic Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Hospital-Acquired Infection (HAI) Diagnostic Revenue in 2023

Figure 7. Hospital-Acquired Infection (HAI) Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Molecular Diagnostics Picture

Figure 9. Blood Tests Picture

Figure 10. Urinalysis Picture

Figure 11. Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 12. Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value Market Share by Type, 2023 & 2030

Figure 13. Product Picture of Urinary Tract Infections

Figure 14. Product Picture of Pneumonia

Figure 15. Product Picture of Surgical Site Infections

Figure 16. Product Picture of Bloodstream Infections

Figure 17. Product Picture of Other Hospital Infections

Figure 18. Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 19. Global Hospital-Acquired Infection (HAI) Diagnostic Sales Value Market Share by Application, 2023 & 2030

Figure 20. North America Hospital-Acquired Infection (HAI) Diagnostic Sales Value (2019-2030) & (US$ Million)

Figure 21. North America Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Country (%), 2023 VS 2030

Figure 22. Europe Hospital-Acquired Infection (HAI) Diagnostic Sales Value (2019-2030) & (US$ Million)

Figure 23. Europe Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Country (%), 2023 VS 2030

Figure 24. Asia Pacific Hospital-Acquired Infection (HAI) Diagnostic Sales Value (2019-2030) & (US$ Million)

Figure 25. Asia Pacific Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Country (%), 2023 VS 2030

Figure 26. South America Hospital-Acquired Infection (HAI) Diagnostic Sales Value (2019-2030) & (US$ Million)

Figure 27. South America Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Country (%), 2023 VS 2030

Figure 28. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Sales Value (2019-2030) & (US$ Million)

Figure 29. Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Country (%), 2023 VS 2030

Figure 30. Key Countries/Regions Hospital-Acquired Infection (HAI) Diagnostic Sales Value (%), (2019-2030)

Figure 31. United States Hospital-Acquired Infection (HAI) Diagnostic Sales Value, (2019-2030) & (US$ Million)

Figure 32. United States Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Type (%), 2023 VS 2030

Figure 33. United States Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Application (%), 2023 VS 2030

Figure 34. Europe Hospital-Acquired Infection (HAI) Diagnostic Sales Value, (2019-2030) & (US$ Million)

Figure 35. Europe Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Type (%), 2023 VS 2030

Figure 36. Europe Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Application (%), 2023 VS 2030

Figure 37. China Hospital-Acquired Infection (HAI) Diagnostic Sales Value, (2019-2030) & (US$ Million)

Figure 38. China Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Type (%), 2023 VS 2030

Figure 39. China Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Application (%), 2023 VS 2030

Figure 40. Japan Hospital-Acquired Infection (HAI) Diagnostic Sales Value, (2019-2030) & (US$ Million)

Figure 41. Japan Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Type (%), 2023 VS 2030

Figure 42. Japan Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Application (%), 2023 VS 2030

Figure 43. South Korea Hospital-Acquired Infection (HAI) Diagnostic Sales Value, (2019-2030) & (US$ Million)

Figure 44. South Korea Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Type (%), 2023 VS 2030

Figure 45. South Korea Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Application (%), 2023 VS 2030

Figure 46. Southeast Asia Hospital-Acquired Infection (HAI) Diagnostic Sales Value, (2019-2030) & (US$ Million)

Figure 47. Southeast Asia Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Type (%), 2023 VS 2030

Figure 48. Southeast Asia Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Application (%), 2023 VS 2030

Figure 49. India Hospital-Acquired Infection (HAI) Diagnostic Sales Value, (2019-2030) & (US$ Million)

Figure 50. India Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Type (%), 2023 VS 2030

Figure 51. India Hospital-Acquired Infection (HAI) Diagnostic Sales Value by Application (%), 2023 VS 2030

Figure 52. Hospital-Acquired Infection (HAI) Diagnostic Industrial Chain

Figure 53. Hospital-Acquired Infection (HAI) Diagnostic Manufacturing Cost Structure

Figure 54. Channels of Distribution (Direct Sales, and Distribution)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Hospital Acquired Infections Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nosocomial Infection Treatment Market Insights Forecast to 2030

Global Defense Hospital Acquired Infections HAI Product Market Research Report 2024

Global Hospital Acquired Infection Testing Market Research Report 2025

Hospital Acquired Urinary Tract Infection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Healthcare Acquired Infection Market Insights Forecast to 2030

Healthcare associated Infectious Disease Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hospital acquired Urinary Tract Infection Testing Market Insights Forecast to 2030

Global Hospital Infection Prevention And Control Market Insights Forecast to 2030

Hospital Acquired Infection Control Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hospital acquired infections HAIs Control Market Research Report 2024

HAIs Control Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hospital Infection Management System Market Research Report 2024

Global Infection Surveillance Solutions Market Research Report 2024

Home Diagnostics for Urinary Tract Infection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Infectious Disease In Vitro Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Surgical Infection Control Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Intra amniotic Infection Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hospital Intelligent System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

120 Pages

Type: Report

Code: QYRE-Auto-21N6899

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13M6952

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29X7355

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28B293

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Hospital-Acquired Infection (HAI) Diagnostic - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-13H8430

Hospital-Acquired Infection (HAI) Diagnostic - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Hospital-Acquired Infection (HAI) Diagnostic - Market Size

Hospital-Acquired Infection (HAI) Diagnostic - Market

Report Scope

Scope of Hospital-Acquired Infection (HAI) Diagnostic - Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Hospital-Acquired Infection (HAI) Diagnostic - Market report?

What are the Application segmentation covered in the Hospital-Acquired Infection (HAI) Diagnostic - Market report?

What are the Type segmentation covered in the Hospital-Acquired Infection (HAI) Diagnostic - Market report?

Recommended Reports

Hospital Infection Diagnostics

Hospital Equipment Systems

Hospital Hygiene Solutions

FEATURED COMPANIES

RELATED REPORTS